Committed Capital

Committed Capital

By Dechert LLPBusiness
Download on the App Store

Committed Capital episodes

  • Secondaries: Dry Powder and Paradigm Shifts

    What’s behind the incredible demand in the PE secondaries market? In this episode, Dechert’s Dean Collins leads a discussion with Coller Capital’s Francois Aguerre and Lazard’s Nick Miles on the latest trends in the space, including the buoyancy of the fundraising market and the types of deals being originated and executed to deploy enormous amounts of dry powder. 

    36 min
  • Sidecar: PREP Act Liability Immunity – Considerations for PE Portfolio Companies During COVID-19

    What should private equity industry players know about the Public Readiness and Emergency Preparedness (“PREP”) Act? In our third Sidecar episode, product liability and mass torts partner Sara Roitman and associate Monica Gorny discuss the broad liability immunity the Act provides to companies involved in COVID-19 diagnosis, treatment and prevention activities, and how it may reduce litigation risk for PE portfolio companies working to address the global pandemic. 

    10 min
  • ESG and Asset Management: Challenges and Opportunities

    How will recent EU regulatory developments and the change of U.S. administration impact ESG in asset management? In this episode, Dechert’s Mikhaelle Schiappacasse, a London-based financial services partner, leads a discussion with Planet First Partners’ Andreea Constantinescu and SilverStreet Capital’s Gary Vaughan-Smith on the latest developments in ESG investing, its role in capital raising and anticipated future trends.

    25 min
  • European Restructurings and the Evolving Role of Alternative Asset Managers

    What types of distressed debt opportunities are available for alternative asset managers in Europe? In this episode, Dechert’s Solomon J. Noh, a London-based restructuring partner, leads a discussion with GLAS Agency’s Natasha Chan and Goldman’s Matthew Whiting on the evolution of restructurings in Europe, the role private equity houses and other alternative asset managers are playing in shaping the restructuring landscape, and what the future holds for investments in distressed debt.

    23 min
  • Sidecar: FTC Suspends HSR Early Termination – How Will It Impact Deal Timing?

    The FTC recently suspended “Early Termination” for deals that are reportable under the Hart-Scott-Rodino (HSR) Act. In our second Sidecar episode, Dechert antitrust/competition partner James Fishkin and counsel Beverly Ang discuss the suspension and its impact on private equity firms, as well as proposed changes to HSR rules that may have a long-term impact. 

    11 min
  • Managing Cybersecurity Risk in Private Equity Transactions: Investing in the Modern Age

    With cyberattacks increasing dramatically in both frequency and sophistication over the past year, cybersecurity preparedness has become more important than ever for private equity investors, and expected by PE investors’ limited partners. In this episode, Brenda Sharton, co-chair of Dechert’s Global Privacy and Cybersecurity practice, leads a discussion with industry specialists Jessica Pizzo of Court Square Capital Partners and John Ansbach of global forensic firm Stroz Friedberg on the importance of evaluating cybersecurity risk as part of due diligence efforts, as well as best practices for mitigating risks post-investment, and steps to take should your organization become a victim of one of these attacks.

    31 min
  • Sidecar: The Corporate Transparency Act – Will My Business Be Affected?

    Committed Capital Sidecar is our new, bite-sized feature which quickly covers a key development affecting the private equity industry.

    In this inaugural Sidecar episode, partners from Dechert’s global private equity practice discuss the administrative and compliance burdens that businesses may face with the recent passage of the U.S. Corporate Transparency Act. Aimed at preventing money laundering and the financing of terrorism through shell companies, the Act requires business entities formed or operating within the United States to disclose the identity of their beneficial owners. The discussion also examines international initiatives in this area and the likely evolution of this legislation.

    9 min
  • A Strong Recovery? PE Life Sciences and Healthcare Investment Opportunities in 2021

    How did PE investments in life sciences and healthcare fare in 2020, and what do this year and future years have in store for those sectors? In this episode, Dechert's Robert Darwin and senior PE leaders with experience at Blue Ox Healthcare, Mid Europa Partners, TPG and GHO Capital discuss key themes and opportunities affecting private equity investment in life sciences and healthcare and how the market is shaping up in the U.S. and Europe, in 2021 and beyond.

    26 min
  • SPACs, Election Impact and Industry Resilience: 2021 Global Private Equity Outlook

    After a surprising surge in Q3 2020, will private equity buyout activity remain strong in 2021? In this special episode, industry leaders from First Atlantic, H.I.G. Capital and One Equity Partners offer their perspectives on findings from Dechert and Mergemarket’s 2021 Global Private Equity Outlook report as well as the global trends likely to impact dealmaking in the year ahead, including the resilience of the industry in the face of COVID-19, implications of the U.S. election, SPACs as an exit path for PE sponsors, and more.

    53 min
  • The Market for Private Equity Financing

    How is the PE industry approaching deal financing in the current environment? In this episode, Dechert and guests from Ares Management, KKR and Vista Credit Partners discuss the latest trends shaping the market, including bank and non-bank lender reactions to COVID, fund portability, the finance landscape for tech and other noteworthy sectors, and where the market may be headed next.

    33 min

About Committed Capital

From the publisher's feed

With private equity firms sitting on record levels of dry powder, opportunities for PE investment and dealmaking still abound. Yet complexities surrounding valuation, due diligence and financing…